Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Tanosaki

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Optics Letters|October 30, 2009
Lasing behavior in a liquid spherical dye laser containing highly scattering nanoparticlesH Taniguchi, M Nishiya, S Tanosaki, et al.
Cancer|August 5, 1998
Relation between microsatellite instability and N-ras mutation and duration of disease free survival in patients with acute leukemiaS Tanosaki, K Inokuchi, T Shimada, et al.
Applied Optics|February 15, 2008
Highly scattering intralipid-10% assisted lasing from microdroplets with acridine orange dyeS Tanosaki, H Taniguchi, K Tsujita, et al.
Radiation Research|November 24, 1999
Chromosome aberrations in bone marrow cells from Japanese patients with thorotrastosisS Tanosaki, M Minamihisamatsu, T Ishihara, et al.
Genes, Chromosomes & Cancer|September 11, 2001
Establishment of a cell line with AML1-MTG8, TP53, and TP73 abnormalities from acute myelogenous leukemiaK Inokuchi, H Hamaguchi, M Taniwaki, et al.
Leukemia Research|July 1, 1996
Possible transforming activity of interferon regulatory factor 2 in tumorigenicity assay of NIH3T3 cells transfected with DNA from chronic myelogenous leukemia patientsM Futaki, K Inokuchi, H Hanawa, et al.
Leukemia|February 13, 2002
Abnormality of c-kit oncoprotein in certain patients with chronic myelogenous leukemia--potential clinical significanceK Inokuchi, H Yamaguchi, M Tarusawa, et al.
Leukemia & Lymphoma|June 27, 1998
Minimal residual disease in acute myelogenous leukemia with PML/RAR alpha or AML1/ETO mRNA and phenotypic analysis of possible T and natural killer cells in bone marrowK Inokuchi, R Iwakiri, M Futaki, et al.
Clinical and Laboratory Haematology|January 24, 2004
Near-triploidy and near-tetraploidy in hematological malignancies and mutation of the p53 geneA Watanabe, K Inokuchi, H Yamaguchi, et al.
Oncogene|December 7, 2005
BRCA1 and FOXA1 proteins coregulate the expression of the cell cycle-dependent kinase inhibitor p27(Kip1)E A Williamson, I Wolf, J O'Kelly, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Optics Letters|October 30, 2009
Lasing behavior in a liquid spherical dye laser containing highly scattering nanoparticlesH Taniguchi, M Nishiya, S Tanosaki, et al.
Cancer|August 5, 1998
Relation between microsatellite instability and N-ras mutation and duration of disease free survival in patients with acute leukemiaS Tanosaki, K Inokuchi, T Shimada, et al.
Applied Optics|February 15, 2008
Highly scattering intralipid-10% assisted lasing from microdroplets with acridine orange dyeS Tanosaki, H Taniguchi, K Tsujita, et al.
Radiation Research|November 24, 1999
Chromosome aberrations in bone marrow cells from Japanese patients with thorotrastosisS Tanosaki, M Minamihisamatsu, T Ishihara, et al.
Genes, Chromosomes & Cancer|September 11, 2001
Establishment of a cell line with AML1-MTG8, TP53, and TP73 abnormalities from acute myelogenous leukemiaK Inokuchi, H Hamaguchi, M Taniwaki, et al.
Leukemia Research|July 1, 1996
Possible transforming activity of interferon regulatory factor 2 in tumorigenicity assay of NIH3T3 cells transfected with DNA from chronic myelogenous leukemia patientsM Futaki, K Inokuchi, H Hanawa, et al.
Leukemia|February 13, 2002
Abnormality of c-kit oncoprotein in certain patients with chronic myelogenous leukemia--potential clinical significanceK Inokuchi, H Yamaguchi, M Tarusawa, et al.
Leukemia & Lymphoma|June 27, 1998
Minimal residual disease in acute myelogenous leukemia with PML/RAR alpha or AML1/ETO mRNA and phenotypic analysis of possible T and natural killer cells in bone marrowK Inokuchi, R Iwakiri, M Futaki, et al.
Clinical and Laboratory Haematology|January 24, 2004
Near-triploidy and near-tetraploidy in hematological malignancies and mutation of the p53 geneA Watanabe, K Inokuchi, H Yamaguchi, et al.
Oncogene|December 7, 2005
BRCA1 and FOXA1 proteins coregulate the expression of the cell cycle-dependent kinase inhibitor p27(Kip1)E A Williamson, I Wolf, J O'Kelly, et al.
Pageof 2